{"organizations": [], "uuid": "8d8981053a6979922e29834dee98a3becc78e009", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-eyenovia-sees-ipo-of-273-mln-share/brief-eyenovia-sees-ipo-of-2-73-mln-shares-of-common-stock-priced-between-10-12-per-share-idUSFWN1P40GU", "country": "US", "domain_rank": 408, "title": "BRIEF-Eyenovia Sees IPO Of 2.73 Mln Shares Of Common Stock Priced Between $10-$12 Per Share", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-09T14:12:00.000+02:00", "replies_count": 0, "uuid": "8d8981053a6979922e29834dee98a3becc78e009"}, "author": "", "url": "https://www.reuters.com/article/brief-eyenovia-sees-ipo-of-273-mln-share/brief-eyenovia-sees-ipo-of-2-73-mln-shares-of-common-stock-priced-between-10-12-per-share-idUSFWN1P40GU", "ord_in_thread": 0, "title": "BRIEF-Eyenovia Sees IPO Of 2.73 Mln Shares Of Common Stock Priced Between $10-$12 Per Share", "locations": [], "entities": {"persons": [{"name": "eyenovia", "sentiment": "none"}], "locations": [], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "per share reuters", "sentiment": "none"}, {"name": "eyenovia inc", "sentiment": "none"}, {"name": "eyenovia inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 12 PM / in 9 minutes BRIEF-Eyenovia Sees IPO Of 2.73 Mln Shares Of Common Stock Priced Between $10-$12 Per Share Reuters Staff 1 Min Read \nJan 9 (Reuters) - Eyenovia Inc: \n* EYENOVIA INC SEES IPO OF 2.73 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $10.00 AND $12.00 PER SHARE - SEC FILING \n* EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $12 MILLION TO COMPLETE PHASE III CLINICAL TRIALS FOR MICROPROST \n* EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $2 MILLION TO COMPLETE PHASE III CLINICAL TRIALS FOR MICROSTAT \n* EYENOVIA SAYS INTENDS TO USE IPO PROCEEDS TOGETHER WITH EXISTING CASH, ABOUT $1.5 MILLION TO COMPLETE MICROTEARS REGISTRATION ACTIVITIES Source: ( bit.ly/2EoBYr8 ) Further company coverage:", "external_links": [], "published": "2018-01-09T14:12:00.000+02:00", "crawled": "2018-01-09T14:33:07.021+02:00", "highlightTitle": ""}